Vantage Awarded a Medical Device Study

Vantage BioTrials Inc. awarded a medical device study for use in Radiology centers for an International Sponsor.

MONTRÉAL, QUÉBEC, April 30, 2010 –Vantage BioTrials, a leading provider of clinical trial development and management services, announced today that it has been awarded a Medical Device study to be conducted at several sites within Canada. The device is an innovative Needle Guidance System used in lung biopsy procedures. Vantage will be providing the complete Clinical Trial Management service for this study, which includes Project Management, Clinical Monitoring, GCP Auditing, DM/EDC, Medical Writing & support services.

About Vantage BioTrials Inc.

Vantage BioTrials Inc. is a privately owned Clinical Research Organization (CRO) based in Montréal Canada that provides superior trial management services and combines a precise blend of clinical development knowledge, talent and resources that will ensure a clinical study’s full potential.

By servicing our Pharmaceutical, Biotech and Generic clients who perform Phase I-IV clinical trials across North America, Europe and Asia, our goal is to exceed their expectations by offering outstanding monitoring, project management and clinical operation services. Our flexibility helps us optimize functionality and improve operational efficiencies for any clinical trial. Our associates are distinguished by their technical expertise and wide range of therapeutic backgrounds, combining with their hands-on experiences, thereby ensuring that our clients receive the highest quality of professional service.